.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Breast cancer continues to impact global health significantly. Consequently, researchers are developing siRNA breast cancer therapy to improve clinical outcomes. This innovative approach uses small interfering RNA (siRNA) to silence specific genes involved in tumor initiation. Furthermore, these molecules inhibit cancer progression by selectively degrading messenger RNA (mRNA) before protein synthesis occurs.
Successful therapy depends heavily on effective delivery mechanisms. Since naked siRNA degrades rapidly in the bloodstream, scientists use sophisticated nanocarriers for protection. For instance, liposomes and metal nanoparticles facilitate cellular uptake and ensure stable transport. Moreover, carbon nanoparticles offer a versatile platform for site-specific targeting. This strategy significantly minimizes systemic side effects for the patient.
One promising aspect of this technology is its ability to mitigate drug resistance. By silencing genes responsible for drug efflux pumps, this therapy can sensitize resistant cells to chemotherapy. Additionally, combining siRNA with traditional treatments allows for a more personalized approach. Therefore, clinicians can target multiple oncogenic pathways simultaneously to prevent tumor recurrence effectively.
Despite the potential benefits, several obstacles remain in clinical translation. Researchers must overcome concerns regarding delivery efficiency and immune responses. Furthermore, suppressing off-target genes is essential to ensure patient safety. However, ongoing breakthroughs in biomimetic nanoparticles suggest that these hurdles are surmountable. These advancements represent a transformative shift toward targeted oncological care.
siRNA targets breast cancer cells by binding to specific messenger RNA sequences. This binding triggers the degradation of the mRNA. Consequently, this silences the expression of genes that drive tumor growth and survival.
The primary delivery vehicles include lipid-based nanoparticles, polymeric nanoparticles, and inorganic carriers like metal or carbon nanoparticles. These systems protect the siRNA from enzymatic degradation and enhance its uptake by tumor cells.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional recommendation. The information provided should not be used for diagnosing or treating a health problem or disease. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
This article reviews siRNA-based therapy for breast cancer, focusing on delivery mechanisms, gene suppression, and overcoming treatment resistance....
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
